Search
2500 results
Trastuzumab (Herceptin)
Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.
5 Environment-tea-lly conscious tips
Simple, easy and fun ways to make your tea more environment-tea-lly conscious.
Fundraise in celebration
Have a birthday, wedding or anniversary coming up? Mark your special occasion by asking your loved ones for donations to Breast Cancer Now. It's a generous and thoughtful way to fundraise.
Sue - on managing lymphoedema - Breast Cancer Now Podcast
Our nurse Addie speaks to Sue about her experience of living with lymphoedema. Sue volunteers for Breast Cancer Care on our Moving Forward courses, sharing her experience to support other women and let them know about the symptoms of this long-term condition, as well as how she manages it.
Request your bookmark bundle
Frequently asked questions about breast screening
Decisions made by the NHS Breast Screening Programme on who should receive breast screening and how often are complicated. Read our FAQ blog explaining more.
Why being a Voice is important to Fola
We asked Fola about her diagnosis, why she became a Breast Cancer Voice, and her favourite moment from our Voices network to date. Our network is a community of people affected by breast cancer, who use their lived experiences to impact breast cancer work and research. Every month, we send our Voices opportunities to get stuck into projects.
Schneider Electric Marathon de Paris
Join our team and take on a marathon in the most beautiful city in the world!
We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT
Baroness Delyth Morgan, Chief Executive of Breast Cancer Now, said:
Laura - hurdles and healing in the 10 years since diagnosis - Breast Cancer Now Podcast
We talk to Laura about the 10 years since her primary breast cancer diagnosis, and about her novel Single Bald Female which touches on some of her experiences.
We respond to NICE decision to recommend tucatinib with trastuzumab and capecitabine for routine use on the NHS
The National Institute for Health and Care Excellence (NICE) has today announced its decision to recommend breast cancer treatment tucatinib with trastuzumab and capecitabine for routine use on the NHS in England, for treating HER2 positive, locally advanced or secondary breast cancer after at least two prior anti-HER2 treatment regimens.